Related Experiment Video
Updated: Jul 19, 2025
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.6K
Myocardial Recovery, Metabolism, and Structure after Cardiac Arrest with Cardioplexol
Carina Hemmerich1, Martina Heep1, Ulrich Gärtner2
1Department of Cardiovascular Surgery, University Hospitals Giessen and Marburg Campus Giessen, Giessen, Germany.
The Thoracic and Cardiovascular Surgeon
|August 10, 2023
Summary
Cardioplexol improves heart function after 45 minutes of ischemia but is less effective than Calafiore cardioplegia after 90 minutes. This study assessed Cardioplexol
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Biomedical Research
Background:
- Cardioplexol shows promise for cardioprotection.
- Previous studies suggest potential benefits in clinical settings.
- Experimental validation is needed to compare its efficacy.
Purpose of the Study:
- To evaluate Cardioplexol's cardioprotective effects during ischemia.
- To compare Cardioplexol with no-flow ischemia (45 minutes).
- To compare Cardioplexol with Calafiore cardioplegia (90 minutes).
Main Methods:
- Isolated rat hearts perfused in a Langendorff apparatus.
- Cardiac arrest induced by Cardioplexol or no-flow (45 min) or Calafiore cardioplegia (90 min).
- Evaluation of cardiac function, metabolic parameters, troponin I, and ultrastructure post-reperfusion.
Main Results:
- After 45 min ischemia, Cardioplexol significantly improved left ventricular developed pressure and relaxation compared to no-flow ischemia.
- After 90 min ischemia, Cardioplexol showed significantly lower left ventricular developed pressure and coronary flow versus Calafiore cardioplegia.
- Troponin I levels were significantly higher with Cardioplexol after 90 min ischemia.
Conclusions:
- Cardioplexol enhances functional recovery following 45 minutes of ischemia.
- Cardioplexol is less effective than Calafiore cardioplegia in protecting the myocardium from ischemia/reperfusion injury after 90 minutes.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
01:28Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:21Cardiopulmonary Resuscitation I: Adult
20
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
20
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
201
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
01:29Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16